Account
Watchlists
Bookmarks
Pricing
Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.
Home
Dashboard
Ask Iris
Discovery
Timeline
Multibagg AI is an AI powered stock research and analysis platform. We provide data, information, content, and analytics for publicly traded Indian companies listed on NSE and BSE. AI can make mistakes, check important information.
Prices might be delayed by a few minutes.
Join our Exclusive Community
Made with 💙 in India. © Finsky Technologies Pvt Ltd. 2025
Bearish
3
Neutral
6
Bullish
5
Bearish
24
Neutral
14
Bullish
8
Bearish
21
Neutral
8
Bullish
3
Dr Lalchandani Labs Limited is a diagnostic and healthcare service provider in Delhi/NCR, offering a range of pathology and diagnostic tests.
The company was established in 2011 and transitioned from a partnership firm to a limited company in 2017.
Dr Lalchandani Labs operates five fully equipped labs and fifteen collection centers, providing comprehensive diagnostic services.
The company has a significant presence in Delhi/NCR with partnerships in major hospitals and offers home collection services enhancing accessibility.
Dr Lalchandani Labs is NABL accredited and prioritizes high-tech diagnostic solutions, partnering with leading global suppliers.
Healthcare
Diagnostic Services
8 Cr
Low Risk
25.4
48.3
—
0.8
28.70
9.80
Sales CAGR
1Y
-7.48%
3Y
-26.63%
5Y
-6.11%
10Y
—
Profit CAGR
1Y
-32.26%
3Y
-23.54%
5Y
-2.53%
10Y
—
ROE
TTM
4.53%
3Y
-1.86%
5Y
2.92%
10Y
—
ROCE
TTM
3.40%
3Y
2.82%
5Y
7.64%
10Y
—
Discover detailed, AI-driven financial summaries that break down key metrics, trends, and insights—empowering you to make smarter investment decisions.
Performance
STEADY PERFORMER
Valuation
REASONABLE
Growth
SLUGGISH
Profitability
LOW MARGIN
Technicals
Bearish
Risk
HIGH RISK
| Symbol | Price | Market Cap | P/E | P/B | Div Yield (%) | ROE (%) | ROCE (%) | ROA (%) |
88.00 | 111 Cr | 23.59 | 2.17 | 0.00 | 35.97 | 39.64 | 0.00 | |
66.96 | 69 Cr | 28.56 | 9.47 | 0.00 | 16.62 | 13.17 | 13.75 | |
18.95 | 26 Cr | 13.44 | 0.39 | 0.00 | 3.32 | 6.57 | 2.69 | |
8.89 | 9 Cr | — | 0.48 | 0.00 | -0.19 | 2.13 | -0.22 | |
39.50 | 9 Cr | 25.99 | 1.02 | 0.00 | 5.19 | 7.65 | 4.22 | |
17.50 | 8 Cr | 25.36 | 0.76 | 0.00 | 4.53 | 3.40 | 2.92 | |
2.61 | 4 Cr | — | 0.39 | 0.00 | -0.26 | -0.12 | -0.16 |
Market Cap
₹ 8 Cr
P/E
25.36
Rights Issue
11 hours ago
Rights Issue Approval by Board
The Board of Directors approved a rights issue of equity shares to raise up to ₹433.31 Lakhs, with eligibility based on a record date to be specified later.
Board Meeting Outcome
11 hours ago
Board Meeting Outcome: Rights Issue Announcement
Dr Lalchandani Labs Ltd announced a rights issue to raise funds through equity shares amounting to Rs 433.31 Lakhs, pending regulatory approvals.
Board Meeting Outcome
6 days ago
Board Meeting Deferred for Fundraising Proposal
The Board Meeting of Dr Lalchandani Labs Ltd. scheduled for December 09, 2025, has been deferred due to ongoing preparatory requirements related to a proposed Rights Issue.
